Breaking News

Emergex COVID-19 Vaccine Candidate Successfully Coated onto Zosano Micro-Needle Patch

May allow for less costly and efficient vaccination programs around the world and increase global preparedness for future pandemics.

Author Image

By: Charlie Sternberg

Associate Editor

Emergex Vaccines Holding Limited’s COVID-19 vaccine candidate has been successfully coated onto Zosano Pharma Corporation’s proprietary microneedle patch system, which consists of an array of approximately two thousand drug-coated titanium microneedles mounted on an adhesive patch that is administered to the skin using a reusable applicator.   Emergex and Zosano have demonstrated that Emergex’s COVID-19 vaccine is stable on the patches over a wide temperature range for up to six months at 40oC...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters